Aarey Drugs & Pharmaceuticals Live BSE/NSE | Aarey Drugs & Pharmaceuticals Fundamenta data | Aarey Drugs & Pharmaceuticals Balance sheet | Aarey Drugs & Pharmaceuticals Quarterly Results | Aarey Drugs & Pharmaceuticals Profit & Loss | Aarey Drugs & Pharmaceuticals Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

69.10
13.68
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

84.89
0.34%
0.74

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

22.53
10.69
-3.60

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.95
42.14
-3.87

PAT CAGR (%)

10 Years
5 Years
3 Years

23.23
43.10
6.14

P:E (Median)

8 Years
5 Years
3 Years

22.72
16.52
10.43

P:BV (Average)

8 Years
5 Years
3 Years

0.56
0.56
0.56

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.36
10.59
7.15

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 25 66 -62% 111 137 -19% 60 78 -24% 64 72 -11%
Expenses 24 65 -63% 111 135 -18% 58 76 -24% 62 69 -10%
EBITDA 2 1 20% 0 2 - 1 2 -34% 1 2 -50%
EBIDTM 6% 2% 0% 2% 2% 3% 2% 3%
Other Income 1 2 -51% 3 2 88% 1 1 16% 1 1 70%
Interest 0 0 12% 0 1 -44% 1 1 -48% 0 0 10%
Depreciation 0 0 -12% 0 0 -76% 0 0 32% 0 0 56%
PBT 2 2 -26% 2 3 -23% 1 2 -10% 1 2 -40%
Tax 0 0 0 1 2 -41% 0 0 0 0 0 0
PAT 1 2 -35% 1 1 35% 1 2 -10% 1 2 -40%
PATM 5% 3% 1% 1% 2% 2% 2% 3%
EPS 0.58 0.90 -36% 0.43 0.31 39% 0.60 0.66 -9% 0.55 0.92 -40%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Net Sales 259 355 349 396 246 213 200 172 130 68 46 Net Sales Growth -27% 2% -12% 61% 15% 7% 16% 32% 93% 46% Cost Of Goods Sold 249 341 337 383 242 210 195 168 127 65 44 Gross Profit 10 14 11 13 4 4 5 4 4 3 3 GP Margin 4% 4% 3% 3% 2% 2% 3% 3% 3% 4% 6% Total Expenditure 256 347 341 386 245 212 198 170 129 66 45 Power & Fuel Cost - 0 0 0 0 0 1 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 1% 1% Employee Cost - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Manufacturing Exp. - 2 0 0 1 0 1 0 0 0 0 % Of Sales - 1% 0% 0% 0% 0% 0% 0% 0% 0% 0% General & Admin Exp. - 2 2 1 1 1 1 1 1 0 0 % Of Sales - 1% 1% 0% 0% 0% 1% 0% 1% 0% 1% Selling & Distn. Exp. - 1 1 1 1 1 1 1 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 1% 0% 0% 1% 1% Miscellaneous Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 3 8 8 10 1 1 1 2 2 1 1 EBITDA Margin 1% 2% 2% 2% 0% 1% 1% 1% 1% 2% 3% Other Income 6 4 3 3 3 3 2 0 0 0 0 Interest 2 2 2 4 2 1 1 1 1 0 0 Depreciation 1 1 1 1 1 1 1 1 1 0 0 PBT 7 9 8 8 2 1 1 1 0 1 1 Tax 2 2 2 2 1 0 0 0 0 0 0 Tax Rate 25% 27% 25% 31% 29% 23% 22% 27% 32% 21% 15% PAT 5 7 6 5 1 1 1 1 0 1 1 PAT before Minority Interest 5 7 6 5 1 1 1 1 0 1 1 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 2% 2% 2% 1% 1% 1% 1% 0% 0% 1% 2% PAT Growth -23% 6% 13% 324% 18% 4% 59% 136% -65% -2% EPS 2.16 2.79 2.64 2.34 0.55 0.47 0.45 0.28 0.12 0.34 0.35

Description

TTM

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Net Sales

259

355

349

396

246

213

200

172

130

Net Sales Growth

-27%

-12%

61%

15%

16%

32%

93%

46%

Cost Of Goods Sold

249

341

337

383

242

210

195

168

127

Gross Profit

GP Margin

Total Expenditure

256

347

341

386

245

212

198

170

129

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

% Of Sales

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

25%

27%

25%

31%

29%

23%

22%

27%

32%

21%

15%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

PAT Growth

-23%

13%

324%

18%

59%

136%

-65%

-2%

EPS

2.16

2.79

2.64

2.34

0.55

0.47

0.45

0.28

0.12

0.34

0.35

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Shareholder's Funds 87 80 49 37 35 35 33 33 22 9 Share Capital 23 23 18 17 17 17 17 14 5 5 Total Reserves 61 55 30 20 19 18 17 19 5 4 Non-Current Liabilities 2 1 2 0 0 0 0 0 0 4 Secured Loans 0 0 0 0 0 0 0 0 0 0 Unsecured Loans 0 0 0 0 0 0 0 0 0 4 Long Term Provisions 0 0 0 0 0 0 0 0 0 0 Current Liabilities 58 88 92 88 80 72 73 54 21 13 Trade Payables 37 78 75 72 67 64 68 48 15 10 Other Current Liabilities 0 4 4 1 0 2 0 1 1 2 Short Term Borrowings 16 3 10 14 11 6 5 4 3 0 Short Term Provisions 4 3 2 1 1 1 1 1 1 1 Total Liabilities 146 170 142 125 115 107 107 87 43 26 Net Block 12 12 12 8 6 4 4 4 5 4 Gross Block 26 25 24 19 17 14 13 12 12 11 Accumulated Depreciation 14 13 12 12 11 10 9 8 8 7 Non Current Assets 13 12 13 8 6 5 8 5 5 5 Capital Work in Progress 0 0 0 0 0 0 0 1 1 2 Non Current Investment 0 0 0 0 0 0 3 0 0 0 Long Term Loans & Adv. 0 0 0 0 0 0 0 0 0 0 Other Non Current Assets 0 0 0 0 0 0 0 0 0 0 Current Assets 133 157 130 117 109 102 99 82 37 21 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 21 15 5 2 4 5 8 8 3 5 Sundry Debtors 106 95 82 72 67 65 66 48 19 13 Cash & Bank 0 3 1 2 0 1 1 1 0 0 Other Current Assets 6 0 0 0 38 31 25 25 14 3 Short Term Loans & Adv. 5 44 42 41 38 27 25 25 14 3 Net Current Assets 75 69 38 28 29 29 26 28 17 8 Total Assets 146 170 142 125 115 107 107 87 43 26

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Shareholder's Funds

Share Capital

Total Reserves

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

146

170

142

125

115

107

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

133

157

130

117

109

102

Current Investments

Inventories

Sundry Debtors

106

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

Total Assets

146

170

142

125

115

107

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Cash From Operating Activity 1 -20 1 6 3 0 3 -9 -11 -1 PBT 9 8 8 2 1 1 1 0 1 1 Adjustment 3 3 5 2 3 2 1 1 1 0 Changes in Working Capital -9 -29 -10 1 -1 -3 1 -11 -13 -2 Cash after chg. in Working capital 3 -18 3 6 3 0 3 -9 -11 -1 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -2 -3 -2 0 0 0 0 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -1 -1 -5 -3 -2 2 -3 0 -1 -2 Net Fixed Assets -1 -1 -5 -3 -2 -1 0 0 -1 -8 Net Investments 0 0 0 0 0 3 -3 0 0 0 Others 0 0 0 0 0 0 0 0 0 6 Cash from Financing Activity -2 23 4 -2 -2 -1 -1 10 12 3 Net Cash Inflow / Outflow -3 2 -1 1 -1 0 -1 1 0 0 Opening Cash & Equivalents 3 1 2 0 1 1 1 0 0 0 Closing Cash & Equivalent 0 3 1 2 0 1 1 1 0 0

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Cash From Operating Activity

-20

-9

-11

-1

PBT

Adjustment

Changes in Working Capital

-9

-29

-10

-1

-3

-11

-13

-2

Cash after chg. in Working capital

-18

-9

-11

-1

Interest Paid

Tax Paid

-2

-3

-2

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-1

-5

-3

-2

-3

-1

-2

Net Fixed Assets

-1

-5

-3

-2

-1

-8

Net Investments

-3

Others

Cash from Financing Activity

-2

-1

Net Cash Inflow / Outflow

-3

-1

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Mar 10
Book Value (Rs.) 36 33 27 22 21 20 20 19 21 20 ROA 4% 4% 4% 1% 1% 1% 1% 0% 2% 4% ROE 8% 10% 13% 4% 3% 3% 2% 1% 8% 9% ROCE 12% 14% 22% 7% 7% 6% 4% 4% 6% 8% Fixed Asset Turnover 14.00 14.30 18.15 13.62 13.87 14.75 13.54 10.56 5.81 6.34 Receivable days 103 93 71 103 112 120 121 94 88 83 Inventory Days 19 10 3 5 8 12 17 16 22 30 Payable days 59 79 69 105 113 120 0 87 70 57 Cash Conversion Cycle 62 24 6 3 7 12 138 23 40 57 Total Debt/Equity 0.19 0.04 0.22 0.40 0.31 0.17 0.15 0.14 0.33 0.48 Interest Cover 5 5 3 2 2 2 2 2 9 582

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Mar 10

Book Value (Rs.)

ROA

ROE

10%

13%

ROCE

12%

14%

22%

Fixed Asset Turnover

14.00

14.30

18.15

13.62

13.87

14.75

13.54

10.56

5.81

6.34

Receivable days

103

112

120

121

Inventory Days

Payable days

105

113

120

Cash Conversion Cycle

138

Total Debt/Equity

0.19

0.04

0.22

0.40

0.31

0.17

0.15

0.14

0.33

0.48

Interest Cover

582

Aarey Drugs & Pharmaceuticals Ltd.

Trading

BSE: 524412 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Aarey Drugs & Pharmaceuticals Ltd.

Trading

BSE: 524412 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update